Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-23T12:01:21.623Z Has data issue: false hasContentIssue false
  • English
  • Français

A case report of long-term survival of metastatic extraskeletal myxoid chondrosarcoma treated with surgery and hypofractionated radiotherapy

Published online by Cambridge University Press:  09 July 2014

Haoming Qiu ,
Mary Hare  and
Yuhchyau Chen
Haoming Qiu*
Affiliation:
Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA
Mary Hare
Affiliation:
Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA
Yuhchyau Chen
Affiliation:
Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA
*
Correspondence to: Haoming Qiu, Department of Radiation Oncology, University of Rochester Medical Center, 601 Elmwood Avenue/Box 647, Rochester, New York 14642, USA. Tel: 585-275-9989, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

We describe the case of a patient with a 10-year history of metastatic extraskeletal myxoid chondrosarcoma (EMC), who underwent repeated surgical excision and ten courses of hypofractionated radiotherapy to locally recurrent or metastatic disease. We review the literature on EMC’s and propose that surgery and radiotherapy can be used to control disease progression and palliate symptoms for extended periods of time with acceptable toxicity profiles.

Keywords

extraskeletal myxoid chondrosarcomametastasisradiation therapyspinal cord radiation tolerance
Type
Case Study
Information
Journal of Radiotherapy in Practice , Volume 13 , Issue 4 , December 2014 , pp. 493 - 497
Copyright
© Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Sandberg, A A. Genetics of chondrosarcoma and related tumors. Curr Opin Oncol 2004; 16 (4): 342–354.CrossRefGoogle ScholarPubMed
2. Oliveira, A M, Nascimento, A G. Phenotypic plasticity and prognostic factors in extraskeletal myxoid chondrosarcoma. Adv Anat Pathol 2000; 7 (2): 73–78.CrossRefGoogle ScholarPubMed
3. Drilon, A D, Popat, S, Bhuchar, G et al.. Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy. Cancer 2008; 113 (12): 3364–3371.CrossRefGoogle ScholarPubMed
4. Kawaguchi, S, Wada, T, Nagoya, S et al. Extraskeletal myxoid chondrosarcoma: a multi-institutional study of 42 cases in Japan. Cancer 2003; 97 (5): 1285–1292.CrossRefGoogle ScholarPubMed
5. Moussavi-Harami, F, Mollano, A, Martin, J A et al. Intrinsic radiation resistance in human chondrosarcoma cells. Biochem Biophys Res Commun 2006; 346 (2): 379–385.CrossRefGoogle ScholarPubMed
6. Overgaard, J. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 1986; 12 (6): 867–872.CrossRefGoogle ScholarPubMed
7. Kirkpatrick, J P, van der Kogel, A J, Schultheiss, T E. Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys 2010; 76 (3 suppl): S42–S49.CrossRefGoogle ScholarPubMed